e-learning
resources
Monograph
2019
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary involvement in systemic lupus erythematosus, Sjögren syndrome and mixed connective tissue disease
Katerina M. Antoniou, Eirini Vasarmidi, Athina Trachalaki, Eleni Bibaki, Bruno Crestani
Source:
Eur Respir Monogr 2019; 86: 106-123
Journal Issue:
Pulmonary Manifestations of Systemic Diseases
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Katerina M. Antoniou, Eirini Vasarmidi, Athina Trachalaki, Eleni Bibaki, Bruno Crestani. Pulmonary involvement in systemic lupus erythematosus, Sjögren syndrome and mixed connective tissue disease. Eur Respir Monogr 2019; 86: 106-123
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Definition and history of sarcoidosis
Evidence of early abnormal airways’ inflammation in children with type 1 diabetes
Related content which might interest you:
Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus
Source: Eur Respir Rev 2011; 20: 277-286
Year: 2011
Lung abnormalities in patients with systemic lupus erythematosus
Source: Eur Respir J 2001; 18: Suppl. 33, 225s
Year: 2001
Management and prognosis of respiratory manifestations revealing systemic lupus erythematosus
Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases
Year: 2007
Lung involvement in systemic lupus erythematosus (SLE) - our own experience
Source: Eur Respir J 2002; 20: Suppl. 38, 60s
Year: 2002
Endothelium dysfunction in systemic lupus erythematosus patients with pulmonary hypertension
Source: Annual Congress 2011 - Clinical features of pulmonary hypertension
Year: 2011
Management of PAH associated with systemic lupus erythematosus (SLE) or mixed connective tissue disease (MCTD): immunosuppressive therapy (IT) alone or combined with PAH specific therapies?
Source: Eur Respir J 2007; 30: Suppl. 51, 344s
Year: 2007
Pulmonary arterial hypertension and systemic lupus erythematosus
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
Interstitial lung disease associated with systemic lupus erythematosus : a monocentric study of 23 cases.
Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases
Year: 2021
Examining pulmonary function measures in patients with systemic lupus erythematosus (SLE)
Source: Virtual Congress 2020 – Rare lung diseases and lung manifestations of extrapulmonary diseases
Year: 2020
A functionally improved case of obstructive impairment caused by systemic lupus erythematosus
Source: Breathe, 17 (2) 200288; 10.1183/20734735.0288-2020
Year: 2021
Systemic lupus erythematosus (SLE): Cyto- and chemokines as possible serum markers for pulmonary involvement?
Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Year: 2012
The profile of lung scintigraphy in systemic lupus erythematosus with chronic pulmonary embolism:a cross-section
Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism
Year: 2020
Sleep-related disturbances in systemic lupus erythematosus
Source: Annual Congress 2009 - Clinical aspects of sleep apnoea
Year: 2009
Clinical manifestations of systemic sclerosis (SS) accompanied with pulmonary involvement
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Early outcomes of patients with systemic lupus erythematosus and antiphospholipid syndrome after pulmonary endarterectomy
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016
Cardio-pulmonary exercise testing in systemic lupus erythematosus patients
Source: Eur Respir J 2005; 26: Suppl. 49, 350s
Year: 2005
Shrinking lung syndrome (SLS) associated with systemic lupus erythematosus (SLE): A series of cases in a university hospital.
Source: International Congress 2019 – Rare and ultra-rare diseases and the lungs: updates and new perspectives
Year: 2019
The nitroxidergic system state at systemic lupus erythematosus-associated pulmonary hypertension
Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Year: 2010
Immunosuppression in systemic lupus erythematosus associated pulmonary arterial hypertension (SLE-APAH): Improvement in exercise and functional capacity
Source: Annual Congress 2011 - Treatment of pulmonary hypertension
Year: 2011
Effectiveness of ²Korargin² in the therapy of pulmonary arterial hypertension in patients with systemic lupus erythematosus
Source: Annual Congress 2011 - Treatment of pulmonary hypertension
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept